RT Journal Article
SR Electronic
T1 APRI score is not predictive of post-surgical outcomes in cholangiocarcinoma patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.12.23285817
DO 10.1101/2023.02.12.23285817
A1 Aslam, Faaiq N
A1 Loveday, Tristan A
A1 Uson Junior, Pedro Luiz Serrano
A1 Truty, Mark
A1 Smoot, Rory
A1 Bekaii-Saab, Tanios
A1 Ahn, Daniel
A1 Sonbol, Mohamad Bassam
A1 Wu, Christina
A1 Stucky, Chee-Chee
A1 Babiker, Hani
A1 Borad, Mitesh J
YR 2023
UL http://medrxiv.org/content/early/2023/02/16/2023.02.12.23285817.abstract
AB Objective To assess the utility of aminotransferase-platelet ratio index (APRI) score in prognosticating post-surgical outcomes in cholangiocarcinoma patients.Methods 152 cholangiocarcinoma patients at the Mayo Clinic that underwent surgical resection were retrospectively analyzed. Statistical analyses were done to determine the relationship between APRI score and demographic factors, laboratory values, pathological features, and outcomes data.Results No relationship between APRI score and demographic factors was identified. There was a correlation between APRI score and ALT, albumin, and bilirubin, but the remaining laboratory parameters showed no correlation. APRI score did not prove to be useful as a prognostic tool as it did not correlate with tumor pathology features and did not correlate with post-surgical recurrence and mortality.Conclusion We found that APRI score was not a prognostic tool for post-surgical outcomes in cholangiocarcinoma patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval from the Mayo Clinic institutional review board was obtained prior to data collection for this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors